The next steps to identify the potential role in AD will be: (1) We will develop a sensitive human ELISA to analyze the mannose-binding protein C in plasma, to determine the plasma levels and if there is a significant difference between healthy controls and AD. Here, MBL2 is linked to Alzheimer disease.